Transcriptional Perturbations in Graft Rejection

Transplantation

Volumn 99, Issue 9, 2015, Pages 1882-1893

  Vitalone, Matthew J ^a   Sigdel, Tara K ^b   Salomonis, Nathan ^c   Sarwal, Reuben D ^b   Hsieh, Szu Chuan ^b   Sarwal, Minnie M ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3PMICRORNA 342; MESSENGER RNA; MICRORNA; MICRORNA 10B; MICRORNA 142 3P; MICRORNA 181A; MICRORNA 192; MICRORNA 204; MICRORNA 215; MICRORNA 25; MICRORNA 615 3P; PROTEIN P53; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GENETIC MARKER;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CELL INFILTRATION; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC DISORDER; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY TUBULE DISORDER; MALE; MICROARRAY ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; WHOLE GENOME MICROARRAY; ACUTE DISEASE; ADULT; ADVERSE EFFECTS; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETIC MARKER; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; LYMPHOCYTE; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOPSY; CASE-CONTROL STUDIES; DATABASES, GENETIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LYMPHOCYTES; MALE; MICRORNAS; MULTIPLEX POLYMERASE CHAIN REACTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84957070389     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000809     Document Type: Article

References (58)

1. Naesens M, Khatri P, Li L, et al. Microarray expression profiling associates progressive histological damage of renal allografts with innate and adaptive immunity. Kidney Int. 2011;80(12):1364-1376.
2. Nankivell BJ, Borrows RJ, Fung CL, et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation. 2004;78(2):242-249.
3. Vitalone MJ, O'Connell PJ, Wavamunno M, et al. Transcriptome changes of chronic tubulointerstitial damage in early kidney transplantation. Transplantation. 2010;89(5):537-547.
4. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl JMed. 2003;349(24):2326-2333.
5. Roedder S, Li L, Alonso MN, et al. A three-gene assay for monitoring immune quiescence in kidney transplantation. J Am Soc Nephrol. 2014.
6. Roedder S, Sigdel T, Salomonis N, et al. The kSORTassay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AARTstudy. PLoS Med. 2014;11(11):e1001759.
7. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006): 350-355.
8. Mack GS. MicroRNA gets down to business. Nat Biotechnol. 2007;25(6): 631-638.
9. Duong Van Huyen JP, Tible M, Gay A, et al. MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J. 2014;35(45):3194-3202.
10. Betts G, Naesens M, Naesens M, et al. Examination of serum miRNA levels in kidney transplant recipients with acute rejection. Transplantation. 2014;97(4):e28-e30.
11. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant. 2004;4(10): 1562-1566.
12. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-723.
13. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753-760.
14. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant. 2007;7(3):518-526.
15. Fleige S, PfafflMW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med. 2006;27(2-3):126-139.
16. Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7: 3.
17. R Development Core Team. R: A language and environment for statistical computing. R. F. f. S. Computing. 2007.
18. Bioconductor. 2011; Available from: http://www.bioconductor.org.
19. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185-193.
20. Jean(ZHIJIN) Wu RI, MacDonald J, Gentry J. GCRMA (2.22.0).
21. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3.
22. Wettenhall JM, Simpson KM, Satterley K, et al. affylmGUI: a graphical user interface for linear modeling of single channel microarray data. Bioinformatics. 2006;22(7):897-899.
23. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98(9):5116-5121.
24. Lemieux S. Probe-level linear model fitting and mixture modeling results in high accuracy detection of differential gene expression. BMC Bioinformatics. 2006;7:391.
25. Chen R, Li L, Butte AJ. AILUN: reannotating gene expression data automatically. Nat Methods. 2007;4(11):879.
26. Zambon AC, Gaj S, Ho I, et al. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics. 2012;28(16):2209-2210.
27. Hsu SD, Lin FM, Wu WY, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 2011;39(Database issue):D163-D169.
28. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83-86.
29. Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004;32(22):e188.
30. Wang FE, Zhang C, Maminishkis A, et al. MicroRNA-204/211 alters epithelial physiology. FASEB J. 2010;24(5):1552-1571.
31. Beuvink I, Kolb FA, Budach W, et al. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res. 2007;35(7):e52.
32. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008;14(5): 844-852.
33. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA. 2006;103(18):7024-7029.
34. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474(7353):649-653.
35. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166.
36. Shen-Orr SS, Tibshirani R, Khatri P, et al. Cell type-specific gene expression differences in complex tissues. Nat Methods. 2010;7(4): 287-289.
37. Li L, Khatri P, Sigdel TK, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012;12(10): 2710-2718.
38. Diehn M, Sherlock G, Binkley G, et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 2003;31(1):219-223.
39. Rebhan M, Chalifa-Caspi V, Prilsuky J, et al. GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 1997; 13(4):163.
40. Wu C, Orozco C, Boyer J, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009;10(11):R130.
41. Uhlen M, Bjorling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4(12):1920-1932.
42. Nilsson P, Paavilainen L, Larsson K, et al. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics. 2005;5(17):4327-4337.
43. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4(1):87-90.
44. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349(2):125-138.
45. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA. 2009;106(13):5330-5335.
46. Spiegel JC, Lorenzen JM, Thum T. Role of microRNAs in immunity and organ transplantation. Expert Rev Mol Med. 2011;13:e37.
47. Manaster I, Goldman-Wohl D, Greenfield C, et al. MiRNA-mediated control of HLA-G expression and function. PLoS One. 2012;7(3):e33395.
48. Asaoka T, Sotolongo B, Island ER, et al. MicroRNA signature of intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. Am J Transplant. 2012;12(2):458-468.
49. Wei L, Wang M, Qu X, et al. Differential expression of microRNAs during allograft rejection. Am J Transplant. 2012;12(5):1113-1123.
50. Roedder S, Kimura N, Okamura H, et al. Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate. PLoS One. 2013; 8(2):e56657.
51. Vitalone MJ, Naesens M, Sigdel T, et al. The dual role of epithelial-tomesenchymal transition in chronic allograft injury in pediatric renal transplantation. Transplantation. 2011;92(7):787-795.
52. Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011;11(10):2110-2122.
53. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318(5858): 1931-1934.
54. Place RF, Li LC, Pookot D, et al. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA. 2008;105(5):1608-1613.
55. Bestard O, Cruzado JM, Rama I, et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol. 2008;19(10):2020-2026.
56. Chrobak P. Control of T cell responses, tolerance and autoimmunity by regulatory T cells: current concepts. Acta Medica (Hradec Kralove). 2003;46(4):131-137.
57. Lu LF, Thai TF, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity. 2009;30(1):80-91.
58. Rouas R, Fayyad-Kazan H, El Zein N, et al. Human natural TregmicroRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol. 2009;39(6):1608-1618.